Stay updated with breaking news from Quotient Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DUBLIN--(BUSINESS WIRE)--The "Bioavailability Enhancement Technologies and Services Market by Drug Class, BCS Classification, Bioavailability Enhancement Approach, Dosage Form and Key Geographies: Industry Trends and Global Forecasts, 2022-2035" report has been added to ResearchAndMarkets.com's offering.This report...
Corporate Update Call to be Held Wednesday, November 16, 2022SAN DIEGO, CA / ACCESSWIRE / November 14, 2022 / Ensysce Biosciences, Inc. ("Ensysce" or the "Company") (NASDAQ:ENSC)(OTC PINK:ENSCW), a clinical-stage
NOTTINGHAM, England, Oct. 18, 2022 /PRNewswire/ -- Quotient Sciences, the drug development and manufacturing accelerator, has completed the expansion of its drug substance manufacturing facility
- New patent grant further secures South Rampart's competitive position in next-generation and disruptive investigational drugs for acute pain -NE...
NOTTINGHAM, England, Sept. 29, 2022 /PRNewswire/ -- Oxilio, a pioneering drug development company repurposing existing drugs to address unmet needs in cancer treatment, and Quotient Sciences